Foghorn Therapeutics Inc. Quarterly Common Stock, Shares Authorized from Q4 2019 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Foghorn Therapeutics Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2019 to Q4 2024.
  • Foghorn Therapeutics Inc. Common Stock, Shares Authorized for the quarter ending December 31, 2024 was 175M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 175M 0 0% Dec 31, 2024 10-K 2025-03-06
Q3 2024 175M 0 0% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 175M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 175M 0 0% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 175M 0 0% Dec 31, 2023 10-K 2025-03-06
Q3 2023 175M 0 0% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 175M 0 0% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 175M 0 0% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 175M 0 0% Dec 31, 2022 10-K 2024-03-07
Q3 2022 175M 0 0% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 175M 0 0% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 175M 0 0% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 175M 0 0% Dec 31, 2021 10-K 2023-03-09
Q3 2021 175M +113M +182% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 175M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 175M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 175M +128M +276% Dec 31, 2020 10-K/A 2022-08-09
Q3 2020 62M Sep 30, 2020 10-Q 2020-12-04
Q4 2019 46.6M Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.